Back to Search
Start Over
(R)-(+)-2-{[(3-Methyl-4-nitropyridin-2-yl)methyl]sulfinyl}-1H-benzimidazoleDRL-IPD Communication No. IPDO-IPM-00262.
- Source :
- Acta Crystallographica Section E, Vol 67, Iss 8, Pp o2190-o2190 (2011)
- Publication Year :
- 2011
- Publisher :
- International Union of Crystallography, 2011.
-
Abstract
- The title compound, C14H12N4O3S, is an intermediate of Dexlansoprazole, a proton pump inhibitor (PPI) mainly developed for anti-ulcer activity. The absolute configuration of the title compound was determined as R. The crystal structure reveals that the molecules form chains along the b axis through N—H...N and C—H...O hydrogen-bonded dimers. These chains are connected via weak C—H...O hydrogen bonds.
- Subjects :
- Crystallography
QD901-999
Subjects
Details
- Language :
- English
- ISSN :
- 16005368
- Volume :
- 67
- Issue :
- 8
- Database :
- Directory of Open Access Journals
- Journal :
- Acta Crystallographica Section E
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.9d2f1d926a0b4ff8bc7b270a45b39406
- Document Type :
- article
- Full Text :
- https://doi.org/10.1107/S1600536811029990